The U.S. Food and Drug Administration is warning consumers in New Mexico and Texas not to eat certain types of raw red tomatoes as it could be linked to the recent salmonella outbreak in the area.

Health officials in New Mexico began testing a variety of tomatoes after it received 57 reported cases of salmonellosis caused by Salmonella Saintpaul in New Mexico and Texas from April 23 through June 1. Seventeen people have also been hospitalized

The U.S. Food and Drug Administration has started a safety review of several drugs known as tumor necrosis factor, or TNF, blockers for a possible association with development of lymphoma and other cancers in children and young adults.

The agency said the drugs, Enbrel, Humira and Remicade, are widely prescribed to treat autoimmune disorders such as rheumatoid arthritis, juvenile rheumatoid arthritis and Crohn's disease

Since May 5 when New York City mandated restaurants to print the calorie count of the meals on menus 81 dining establishments have been served notice by the city Health Department for violation of the law.

Among those found guilty were Dunkin' Donuts, T.G.I. Friday's and McDonalds. Deputy Commissioner Jessica Leighton of the Health Department told the New York Post, the city is not yet fining the violating restaurants since the law was still on a educational phase. "We are trying to help the owners of the establishments understand the new rule," Leighton said

The U.S. Food and Drug Administration plans to introduce new environment-friendly asthma inhalers for patients by the end of this year. Albuterol asthma inhalers that contain chlorofluorocarbons, or CFCs will no longer be made or sold in the U.S.

CFCs damage the Earth's protective ozone layer, which shields the planet from harmful ultraviolet radiation. The federal agency is urging patients not to wait until the last minute to switch to newer alternatives as the new ones available by December end will be powered by ozone-friendly HFAs, or hydrofluoroalkanes

The U.S. Food and Drug Administration (FDA) on Wednesday proposed new changes to labels on drugs prescribed to pregnant and breast-feeding women.

If enacted, the new system would replace a 30-year-old system for classifying drugs in favor of labels that provide more detailed information to doctors prescribing the drugs